Prot# CPG 10101-003: CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase 1B Open Label Randomized Trial of CPG 10101 Alone, with Interferon, Ribavirin, or Interferon and Ribavirin in the Treatment of Relapsed HCV Subjects

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/058/10/10

Funding

  • Coley Pharmaceutical Group, Inc. (CPG 10101-003)